Bluebird Bio (BLUE) Shareholder Baker Bros Advisors LP Decreased Its Stake by $7.38 Million as Valuation Declined; Apple (AAPL) Shareholder Edgewood Management Has Cut Holding by $526,097 as Stock Value Declined

April 18, 2018 - By Winifred Garcia

Apple Inc. (NASDAQ:AAPL) Logo

Julian Baker decreased its stake in Bluebird Bio Inc. (BLUE) by 17.16% based on its latest 2017Q4 regulatory filing with the SEC. Baker Bros Advisors Lp sold 41,441 shares as the company’s stock declined 2.42% with the market. The hedge fund run by Julian Baker held 200,000 shares of the health care company at the end of 2017Q4, valued at $35.62M, down from 241,441 at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Bluebird Bio Inc. for a number of months, seems to be less bullish one the $8.79 billion market cap company. The stock increased 2.81% or $4.8 during the last trading session, reaching $175.85. About 264,362 shares traded. bluebird bio, Inc. (NASDAQ:BLUE) has risen 86.28% since April 18, 2017 and is uptrending. It has outperformed by 74.73% the S&P500.

Edgewood Management Llc decreased its stake in Apple Inc (AAPL) by 1.84% based on its latest 2017Q4 regulatory filing with the SEC. Edgewood Management Llc sold 3,113 shares as the company’s stock declined 3.81% with the market. The institutional investor held 166,229 shares of the computer manufacturing company at the end of 2017Q4, valued at $28.13M, down from 169,342 at the end of the previous reported quarter. Edgewood Management Llc who had been investing in Apple Inc for a number of months, seems to be less bullish one the $903.63B market cap company. The stock decreased 0.08% or $0.15 during the last trading session, reaching $178.09. About 12.29M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 19.49% since April 18, 2017 and is uptrending. It has outperformed by 7.94% the S&P500.

Since December 7, 2017, it had 0 buys, and 4 selling transactions for $19.89 million activity. The insider SCHILLER PHILIP W sold $11.56 million.

Investors sentiment increased to 0.73 in Q4 2017. Its up 0.03, from 0.7 in 2017Q3. It improved, as 50 investors sold AAPL shares while 1023 reduced holdings. 151 funds opened positions while 637 raised stakes. 2.98 billion shares or 0.18% more from 2.97 billion shares in 2017Q3 were reported. 24,492 are owned by Orleans Cap Mgmt Corp La. Moreover, Wedgewood Invsts Pa has 0.28% invested in Apple Inc. (NASDAQ:AAPL) for 2,028 shares. Addenda owns 83,708 shares. Hedeker Wealth Ltd Liability Corp holds 4.33% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 32,851 shares. Holt Capital Advsr Limited Liability Dba Holt Capital Limited Partnership has invested 1.68% in Apple Inc. (NASDAQ:AAPL). Laurion Capital Mgmt Limited Partnership accumulated 463,502 shares or 0.4% of the stock. Lesa Sroufe And has 2,036 shares. Martin Tn has invested 2.62% in Apple Inc. (NASDAQ:AAPL). Veritas Inv Mngmt (Uk) Limited holds 0.11% or 1,757 shares. Noven Fincl Grp holds 0.47% or 4,799 shares. Cim Ltd Liability Corporation has invested 4.08% in Apple Inc. (NASDAQ:AAPL). Mcdaniel Terry & has 1.58% invested in Apple Inc. (NASDAQ:AAPL) for 52,853 shares. Silvercrest Asset Gp Llc stated it has 0.39% in Apple Inc. (NASDAQ:AAPL). Bradley Foster And Sargent Ct has 497,663 shares. Fairfield Bush holds 2.15% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 46,085 shares.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on May, 1 after the close. They expect $2.71 EPS, up 29.05% or $0.61 from last year’s $2.1 per share. AAPL’s profit will be $13.75B for 16.43 P/E if the $2.71 EPS becomes a reality. After $3.89 actual EPS reported by Apple Inc. for the previous quarter, Wall Street now forecasts -30.33% negative EPS growth.

Edgewood Management Llc, which manages about $9.25B and $22.97 billion US Long portfolio, upped its stake in Spdr S&P 500 Etf Tr (SPY) by 26,454 shares to 31,070 shares, valued at $8.29M in 2017Q4, according to the filing. It also increased its holding in Ecolab Inc (NYSE:ECL) by 1.80 million shares in the quarter, for a total of 5.31M shares, and has risen its stake in S&P Global Inc.

Among 54 analysts covering Apple Inc. (NASDAQ:AAPL), 35 have Buy rating, 1 Sell and 18 Hold. Therefore 65% are positive. Apple Inc. had 394 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Tuesday, April 3 by RBC Capital Markets. The firm has “Buy” rating by UBS given on Wednesday, October 12. The stock of Apple Inc. (NASDAQ:AAPL) earned “Overweight” rating by Barclays Capital on Wednesday, October 14. The rating was maintained by Brean Capital with “Buy” on Monday, April 4. Morgan Stanley maintained it with “Overweight” rating and $120 target in Wednesday, April 27 report. The firm earned “Buy” rating on Friday, June 9 by Drexel Hamilton. The stock of Apple Inc. (NASDAQ:AAPL) has “Hold” rating given on Friday, February 2 by Bernstein. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Friday, September 11 by Stifel Nicolaus. The firm has “Outperform” rating by FBR Capital given on Friday, February 12. The company was maintained on Wednesday, October 28 by Mizuho.

Among 26 analysts covering bluebird bio (NASDAQ:BLUE), 14 have Buy rating, 2 Sell and 10 Hold. Therefore 54% are positive. bluebird bio had 92 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, March 5 by William Blair. The stock of bluebird bio, Inc. (NASDAQ:BLUE) has “Equal-Weight” rating given on Wednesday, March 21 by Morgan Stanley. Bernstein maintained it with “Hold” rating and $211.0 target in Thursday, February 22 report. The stock of bluebird bio, Inc. (NASDAQ:BLUE) has “Hold” rating given on Wednesday, December 20 by Oppenheimer. The rating was initiated by Leerink Swann with “Outperform” on Wednesday, February 3. Morgan Stanley downgraded bluebird bio, Inc. (NASDAQ:BLUE) rating on Monday, December 7. Morgan Stanley has “Equal-Weight” rating and $69 target. The stock has “Equal-Weight” rating by Morgan Stanley on Tuesday, September 8. The stock has “Sell” rating by Cantor Fitzgerald on Monday, December 11. The firm earned “Neutral” rating on Monday, February 6 by TH Capital. The company was maintained on Saturday, August 15 by Roth Capital.

Investors sentiment decreased to 1.51 in Q4 2017. Its down 0.28, from 1.79 in 2017Q3. It fall, as 21 investors sold BLUE shares while 79 reduced holdings. 71 funds opened positions while 80 raised stakes. 50.71 million shares or 3.40% more from 49.05 million shares in 2017Q3 were reported. Tekla Cap Mngmt Ltd Liability holds 0.32% or 47,093 shares in its portfolio. Fmr reported 0.15% in bluebird bio, Inc. (NASDAQ:BLUE). Guggenheim Capital Ltd Liability Corp accumulated 0.01% or 26,990 shares. Iowa-based Principal Fincl Group has invested 0.01% in bluebird bio, Inc. (NASDAQ:BLUE). California Employees Retirement System reported 96,046 shares or 0.02% of all its holdings. Highland Cap LP invested 0.15% in bluebird bio, Inc. (NASDAQ:BLUE). Moreover, Da Davidson has 0% invested in bluebird bio, Inc. (NASDAQ:BLUE). Cormorant Asset Mngmt Lc holds 1.49% or 80,000 shares. Polar Llp invested in 17,500 shares or 0.03% of the stock. Tiaa Cref Invest Management Llc owns 240,813 shares for 0.03% of their portfolio. 131,484 are held by Columbus Circle. Td Asset Mgmt stated it has 0.01% in bluebird bio, Inc. (NASDAQ:BLUE). 20,000 were accumulated by Sivik Global Health Ltd Com. Teachers Retirement System Of The State Of Kentucky stated it has 0.03% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE). Bnp Paribas Arbitrage holds 10,049 shares.

Baker Bros Advisors Lp, which manages about $8.20B and $11.54B US Long portfolio, upped its stake in Gw Pharmaceuticals Plc (NASDAQ:GWPH) by 146,800 shares to 221,800 shares, valued at $29.28 million in 2017Q4, according to the filing. It also increased its holding in Abeona Therapeutics Inc. by 300,000 shares in the quarter, for a total of 1.98 million shares, and has risen its stake in Sage Therapeutics Inc. (NASDAQ:SAGE).

Analysts await bluebird bio, Inc. (NASDAQ:BLUE) to report earnings on May, 2. They expect $-2.00 EPS, down 19.05% or $0.32 from last year’s $-1.68 per share. After $-2.52 actual EPS reported by bluebird bio, Inc. for the previous quarter, Wall Street now forecasts -20.63% EPS growth.

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>